Autopsy report · NCT04815083

Fluorescence Imaging of Carcinoma During Breast Conserving Surgery

“Study terminated due to closure of Sponsor business”

The sponsor’s own words in the registry.

Life of this trial

• Registered 1 month before it started.
• Ran for about 3 years 8 months before it stopped.
• 57 participants enrolled.
• Results were posted on the registry 8 months after it ended.

Vital statistics

Status

Terminated

Phase

Phase 3

Sponsor

SBI ALApharma Canada, Inc.

Sponsor type

Industry

Conditions

Breast Neoplasm Female; Breast Cancer

Interventions

Aminolevulinic Acid Hydrochloride; Eagle V1.2 Imaging System; Placebo

Participants

57

Sites

7

Countries

United States

Trials that died the same way

• Study of Upifitamab Rilsodotin in Combination With Carboplatin in Participants With High-grade Serous Ovarian Cancer
  “Study Terminated by Sponsor” (88% match in meaning)
• Ritlecitinib (PF-06651600) in Participants With Chronic Spontaneous Urticaria
  “Sponsor terminated study” (87% match in meaning)
• Valproic Acid (VPA) for Acute Kidney Injury (AKI) in Liver Transplant Patients
  “Study terminated by the Sponsor” (87% match in meaning)
• Comprehensive Medication Monitoring on Heart Failure Patient Outcomes
  “Study terminated by sponsor for commercial reasons” (86% match in meaning)
• A Study Evaluating the Effects of GLPG3970 Given as an Oral Treatment for 12 Weeks in Adults With Active Primary Sjögren's Syndrome (pSS)
  “Study was terminated based on Sponsor decision” (84% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.